3rd Circuit: Unapproved Drug Ingredient Doesn’t Create ‘New Drug’ Liability
PHILADELPHIA — The Third Circuit U.S. Court of Appeals affirmed a trial court ruling that a generic drugmaker’s failure to disclose active ingredients from an unauthorized supplier did not constitute the...To view the full article, register now.
Already a subscriber? Click here to view full article